Black Diamond Therapeutics, Inc. (BDTX) Earnings
|
Expand Research on BDTX
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +478.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/26  |
Q425 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | $0.98 | $0.05 | +$0.93 | $70M | $28M | N/A |  | | Details | |
| 5/9/25 |
Q125 | N/A | $0.05 | N/A | N/A | $28M | N/A | N/A | N/A | ||
| 5/7/25 |
Q125 | N/A | $0.05 | N/A | N/A | $28M | N/A | N/A | N/A | ||
| 3/6/25 |
Q424 | -$0.28 | -$0.35 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 11/5/24 | Q324 | -$0.28 | -$0.37 | +$0.09 | N/A | N/A | N/A | | | Details |
